Leading medical cannabis company AusCann Group Holdings
(ASX:AC8) has completed its second harvest with DayaCann joint venture partner Fundación Daya in Chile.
The second crop yielded 620 kilograms of dried cannabis product, an increase of over 50 per cent from the first crop.
AusCann sees the South American market as internationally significant following recent legislative changes in Argentina, which has joined Chile, Colombia and Uruguay in legalising medical cannabis for therapeutic purposes.
Shares in AusCann Group Holdings
(ASX:AC8) closed down 2.72 per cent to $1.43 yesterday
